Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MultiCell Technologies Inc

+ Add to Watchlist

MCET:US

0.0003 USD 0.00000.00%

As of 14:45:49 ET on 06/02/2015.

Snapshot for MultiCell Technologies Inc (MCET)

Open: 0.0003 Day's Range: 0.0003 - 0.0003 Volume: 52,000
Previous Close: 0.0003 52wk Range: 0.0002 - 0.0015 1-Yr Rtn: -65.71%

Stock Chart for MCET

No chart data available.
  • MCET:US 0.0003
  • 1D
  • 1M
  • 1Y
0.0003
Interactive MCET Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MCET

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0001
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 1.46
Shares Outstanding (M) 4,863.45
30 Day Average Volume 14,050,434
Price/Book (mrq) -
Price/Sale (ttm) 25.1722
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MCET

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MCET

MultiCell Technologies Inc. is a biotechnology company. The Company develops therapeutic candidates based on modulation of the immune system plus new antiviral treatments to address influenza and other infectious diseases. MultiCell produces cell lines used by pharmaceutical companies to screen and develop new drugs and therapeutics.

W Gerald Newmin "Jerry"Chairman/President/CEO/CFOBarbara CorbettInvestor Relations
More Company Profile & Key Executives for MCET

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil